Physician profile
Ryan A Wilcox
NPI 1689651325
$5,139.88
in general payments reported to CMS, 2019-2025
17 companies · $32.73 in 2025
The $32.73 reported for 2025 was less than what a typical Medical Oncology provider received nationally (typical 2025 total: $1,158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $59.34 · 2020: $2,250 · 2021: $2,625 · 2022: $173 · 2025: $32.73.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $32.73.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $32.73 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Otsuka Pharmaceutical Co., Ltd. | $2,625.00 | 2021 | |
| Kyowa Kirin, INC. | $2,358.33 | 2020-2025 | |
| Incyte Corporation | $97.21 | 2022 | |
| Merck Sharp & Dohme LLC | $59.34 | 2019 |
13 companies reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ryan Wilcox listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.